Lupus Society of Alberta

For the LSA, the grace, flexibility, and complexity of the willow tree have come to represent the qualities people develop as they meet the challenges posed by lupus.

Just thinking about the beauty and endurance of the willow - bending but not breaking in the face of strong winds - can be an empowering image for those whose lives are affected by lupus.

The faces of lupus ....

Lupus is called 'the disease with a thousand faces' because the symptoms and course of the disease differ so much from person to person. Lupus affects people of all ages, genders and ethnic backgrounds.

Any face could be the face of lupus.

Click here to take part in a 'Faces of Lupus' book project.

Imagine Canada is a group that supports charities and nonprofits so they can, in turn, support the Canadians and communities they serve. Imagine Canada's Ethical Code Program sets standards for charitable organizations to manage and report their financial affairs responsibly. This is important because, as a donor, you are entitled to transparency and the greatest impact possible for your donation.

NEWS

Sources of reliable lupus / health news:

Recent Highlights

June 2, 2011 - Rituxan (rituximab) advisory from Health Canada - four people with rheumatoid arthritis have died after an intravenous infusion of this medication. This medication is also used in the treatment of lupus. Consumers who require additional information regarding the use od Rituxan can contact the drug information department at Hoffmann-La Roche at: 1-888-762-4388.

May 26, 2011 - Live from London - LRI Research Director Jennifer Bell, PhD provides: Lupus updates from the annual European Congress in Rheumatology (EULAR).

May 4, 2011 - Alberta Health and Wellness launches its new MyHealthAlberta website.

This website was created by the Alberta Government in partnership with Alberta Health Services to provide reliable health information that represents the knowledge, practices, and expertise of health professionals in Alberta.

March 9, 2011 - The Lupus Foundation of America Applauds the FDA's Decision to Approve the new drug - Benlysta®.

Benlysta® is the first new treatment for lupus in more than 52 years. Check out the Lupus Foundation of America website for more details.

While the approval of Benlysta® in the US is certainly cause for excitement, there are a couple of things to keep in mind here in Alberta:

Benlysta® is not for everyone who has lupus. It has been approved in the US for adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are already receiving, but not fully responding, to standard therapy.

While the FDA has approved Benlysta® for use in the US, it has not yet been approved for use in Canada. Regulatory applications to have Benlysta® approved for use in Canada have been submitted and are currently under consideration. The date that Benlysta® will be available for use in Alberta is currently unknown.

	To provide education and support on lupus and lupus related issues and enable research to find effective treatment and cures.
	Home \| Charitable Registration Number \| Disclaimer
	©2011 Lupus Society of Alberta